stockrowIQVIA Holdings Inc.
IQV Healthcare Diagnostics & Research
IQVIA Holdings Inc.’s revenue for fiscal 2025 (year ended December 2025) was $16.3 billion, up 5.87% from fiscal 2024.
- Revenue
- +8.00%
- EPS
- +10.2%
- Free cash flow
- −21.3%
- Total debt
- +7.42%
Quarter to September 2026, against a year earlier
Follow IQV
Alert me
IQVIA Holdings Inc. (IQV) Return on equity
IQVIA Holdings Inc.'s return on equity over the twelve months to 30 September 2026 was 21.3%, down 0.1 percentage points from fiscal 2025 (21.4%). Over the past ten years it has ranged from −74.4% (fiscal 2015) to 22.9% (fiscal 2023); the current reading is higher than 82% of that period. That is above the Diagnostics & Research industry median of 0.00% and above the Healthcare sector median of −26.0%.
Return on equity, annual
Embed this chart
Annual newest first
| Period | Return on equity | Change (points) |
|---|---|---|
| FY2025 | 21.4% | (1.13) |
| FY2024 | 22.6% | (0.32) |
| FY2023 | 22.9% | 4.39 |
| FY2022 | 18.5% | 2.80 |
| FY2021 | 15.7% | 11.23 |
| FY2020 | 4.45% | 1.56 |
| FY2019 | 2.89% | (0.52) |
| FY2018 | 3.41% | (11.52) |
| FY2017 | 14.9% | 13.24 |
| FY2016 | 1.69% | 76.11 |
Against its own ten years
Return on equity against peers
| Company | Return on equity |
|---|---|
| IDXX IDEXX Laboratories, Inc. compare | 68.9% |
| ILMN Illumina, Inc. compare | 32.4% |
| IQV IQVIA Holdings Inc. | 21.3% |
| A Agilent Technologies, Inc. compare | 21.0% |
| DGX Quest Diagnostics Incorporated compare | 14.8% |
| LH Labcorp Holdings Inc. compare | 11.5% |
| WAT Waters Corporation compare | 0.00% |
| NTRA Natera, Inc. compare | −10.6% |
| MTD Mettler-Toledo International, Inc. compare | −1,089.1% |
| Diagnostics & Research industry median | 0.00% |
| Healthcare sector median | −26.0% |
| Market median | 1.01% |
What Return on equity is
ROE shows how much profit a company earns for its shareholders on the equity they have in the business.
Annual: Net Income Allotted to Shareholders ÷ Average Common Equity; TTM: Net Income Allotted to Shareholders ÷ Average Common Equity (latest quarter)
More on IQV
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement